XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,336,544 | -20.4% | 68,400 | -10.3% | 0.00% | – |
| Q2 2023 | $2,934,894 | +172.7% | 76,231 | +153.5% | 0.00% | – |
| Q1 2023 | $1,076,170 | +53.3% | 30,069 | +68.9% | 0.00% | – |
| Q4 2022 | $701,854 | -67.1% | 17,800 | -69.9% | 0.00% | – |
| Q3 2022 | $2,134,000 | -24.5% | 59,100 | -36.4% | 0.00% | – |
| Q2 2022 | $2,828,000 | -6.5% | 92,989 | -6.0% | 0.00% | – |
| Q1 2022 | $3,023,000 | -67.0% | 98,891 | -66.2% | 0.00% | – |
| Q4 2021 | $9,154,000 | +70.6% | 293,000 | -16.5% | 0.00% | – |
| Q3 2021 | $5,365,000 | +454.2% | 351,079 | +575.4% | 0.00% | – |
| Q2 2021 | $968,000 | +108.2% | 51,981 | +100.1% | 0.00% | – |
| Q1 2021 | $465,000 | +662.3% | 25,982 | +34.8% | 0.00% | – |
| Q2 2017 | $61,000 | – | 19,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |